---
id: 199
title: Beta-D-Glucan (BDG) for Invasive Fungal Infections
category: diagnostics
subcategory: laboratory
tags: [beta-D-glucan, BDG, Pneumocystis, Candida, Aspergillus, galactomannan, fungal-biomarker]
difficulty: medium
---

## Question

How is beta-D-glucan (BDG) used? Use **"Positive: *Candida*, *Aspergillus*, *Pneumocystis* | Negative: *Cryptococcus*, *Mucor* | False+: Gauze, Hemodialysis, IVIG"** framework.

## Answer

### **Beta-D-Glucan (BDG) Overview:**

**What It Is:**
- **Fungal cell wall component** (polysaccharide)
- **Released into serum** during invasive fungal infection

**Detects:**
- ***Candida* species** (candidemia, invasive candidiasis)
- ***Aspergillus* species** (invasive aspergillosis)
- ***Pneumocystis jirovecii*** (PCP)
- **Other fungi:** *Fusarium*, *Trichosporon*, endemic fungi (*Histoplasma*, *Coccidioides*, *Blastomyces*)

**Does NOT Detect:**
- ***Cryptococcus*** (low/absent BDG in cell wall)
- **Mucorales** (*Rhizopus*, *Mucor*, *Rhizomucor*) - zygomycetes lack BDG

### **Interpretation:**

**Thresholds (Assay-Dependent):**
- **Negative:** <60-80 pg/mL (varies by assay)
- **Positive:** ≥80-500 pg/mL
- **Borderline:** Repeat test (trend over time)

**Sensitivity/Specificity:**
- ***Candida*:** Sensitivity 75-85%, specificity 80-85%
- ***Aspergillus*:** Sensitivity 70-80%, specificity 80-85%
- ***Pneumocystis*:** Sensitivity 90-95%, specificity 80-85%

### **False Positives (Common):**

**Healthcare-Associated:**
- **Hemodialysis** (cellulose membranes)
- **IVIG (intravenous immunoglobulin)** administration
- **Surgical gauze** (contact with serosal surfaces)
- **Albumin infusion** (some preparations)
- **Amoxicillin-clavulanate** (some formulations)

**Other:**
- **Bacteremia** (Gram-positive bacteria with BDG-like structures)
- **Severe mucositis**

### **Clinical Uses:**

**1. Diagnosis of Invasive Fungal Infection (IFI):**
- **Adjunct test** (NOT standalone)
- **Combine with:** Clinical context, imaging (CT chest), cultures, galactomannan (for *Aspergillus*)

**Invasive Candidiasis:**
- **Positive BDG** + clinical suspicion (fever, risk factors) → empiric therapy while awaiting cultures

**Invasive Aspergillosis:**
- **Positive BDG + galactomannan** + nodules on CT → presumptive diagnosis

***Pneumocystis* Pneumonia (PCP):**
- **High sensitivity** (90-95%)
- **Useful if:** BAL not feasible, negative induced sputum
- **Very high BDG** (often >500 pg/mL) suggests PCP

**2. Monitor Treatment Response:**
- **Declining BDG** suggests response to therapy
- **Rising/persistently elevated BDG** suggests treatment failure

**3. Guide Antifungal Discontinuation:**
- **Negative BDG** (after positive) supports stopping empiric antifungals (if cultures negative, clinical improvement)

### **Limitations:**

**NOT Specific:**
- **Cannot identify fungal species** (positive for multiple fungi)
- **Cannot distinguish colonization from infection** (if low-level positive)

**Affected by Timing:**
- **May be negative early** in infection (before fungal load sufficient)
- **Serial testing** increases sensitivity

**Variable Performance:**
- **Prophylaxis:** BDG may be falsely negative (if on echinocandin prophylaxis - inhibits BDG synthesis)

### **Combination with Galactomannan (GM):**

**For *Aspergillus*:**
- **BDG + GM** increases sensitivity (either positive = 85-90% sensitivity)
- **Both negative:** High negative predictive value (unlikely invasive aspergillosis)

| Test | *Candida* | *Aspergillus* | *Cryptococcus* | *Mucor* | *Pneumocystis* |
|------|-----------|---------------|----------------|---------|----------------|
| **BDG** | ✓ | ✓ | ✗ | ✗ | ✓ |
| **Galactomannan** | ✗ | ✓ | ✗ | ✗ | ✗ |
| **Cryptococcal Ag** | ✗ | ✗ | ✓ | ✗ | ✗ |

## Key Points

### **BDG Positive:**
- ***Candida*, *Aspergillus*, *Pneumocystis*** (most common)
- **Endemic fungi:** *Histoplasma*, *Coccidioides*, *Blastomyces*
- ***Fusarium*, *Trichosporon***

### **BDG Negative:**
- ***Cryptococcus*** (lacks BDG in cell wall)
- **Mucorales** (*Rhizopus*, *Mucor*, *Rhizomucor*)

### **False Positives Common:**
- **Hemodialysis, IVIG, surgical gauze** (most common)
- **Amoxicillin-clavulanate, albumin infusion**
- **Bacteremia** (some Gram-positives)

### **High BDG (>500 pg/mL):**
- **Suggests *Pneumocystis*** (very high levels typical)
- **vs. *Candida/Aspergillus*:** Moderate elevation (100-500 pg/mL)

### **NOT Standalone Test:**
- **Combine with:** Clinical context, imaging, cultures, galactomannan
- **Serial testing** increases sensitivity

### **Clinical Pearls:**
- **Positive:** *Candida*, *Aspergillus*, *Pneumocystis* (NOT *Cryptococcus*, *Mucor*)
- **False positives:** Hemodialysis, IVIG, gauze, bacteremia
- **High BDG (>500 pg/mL):** Think *Pneumocystis*
- **Combine with galactomannan** for *Aspergillus* (increases sensitivity)
- **Use for monitoring:** Declining BDG = response to therapy

## Sources

- [IDSA: Aspergillosis Guidelines 2024]
- [CID: Beta-D-Glucan for IFI Diagnosis 2024]

## Media

N/A
